featured
Cannabinoid Receptor Type 1 and mu-Opioid Receptor Polymorphisms Are Associated With Cyclic Vomiting Syndrome
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The American Journal of Gastroenterology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Cannabinoid Receptor Type 1 and mu-Opioid Receptor Polymorphisms Are Associated With Cyclic Vomiting Syndrome
Am. J. Gastroenterol 2017 Mar 28;[EPub Ahead of Print], A Wasilewski, U Lewandowska, P Mosinska, C Watala, M Storr, J Fichna, T VenkatesanFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.